Tubular carcinoma of the breast: A histologic subtype indicative of breast-conserving therapy

被引:8
作者
Anan, K [1 ]
Mitsuyama, S [1 ]
Tamae, K [1 ]
Nishihara, K [1 ]
Iwashita, T [1 ]
Abe, Y [1 ]
Ihara, T [1 ]
Nakahara, S [1 ]
Katsumoto, F [1 ]
Takeda, S [1 ]
Toyoshima, S [1 ]
机构
[1] Kitakyushu Municipal Med Ctr, Dept Surg, Kokurakita Ku, Kitakyushu, Fukuoka 8020077, Japan
来源
SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY | 2000年 / 30卷 / 12期
关键词
margin; extensive intraductal carcinoma; irradiation; tubular carcinoma; breast;
D O I
10.1007/s005950070001
中图分类号
R61 [外科手术学];
学科分类号
摘要
We reviewed the clinical and pathologic features of pure tubular carcinoma of the breast with particular emphasis on the reported risk factors associated with local recurrences and survival following breast-conserving therapy. Of 1653 cases of invasive breast cancer, 12 (0.7%) were identified as pure tubular carcinoma. Clinical/pathologic features of pure tubular carcinoma were compared with those of T1 invasive carcinoma of all other histologic types (T1 IC). Of the 12 patients with pure tubular carcinoma (median tumor diameter 1.4cm; range 0.5-3.0cm), a multicentric association was identified in one patient while a multifocal association was seen in two. One patient had nodal metastatic disease out of the ten who underwent axillary dissection. No lymphatic vessel invasion was identified in any tumors (P < 0.1 vs T1 IC). In addition, extensive intraductal spread was not present in any tumors (P < 0.05 vs T1 IC). This study shows that patients with pure tubular carcinoma are appropriate candidates for breast-conserving therapy based on the clinical/pathologic features. When a multifocal association is suspected preoperatively, either a wide local excision or a quadrantectomy which includes other lesions is thus recommended.
引用
收藏
页码:1057 / 1061
页数:5
相关论文
共 30 条
[1]   MEETING HIGHLIGHTS - A REAPPRAISAL OF RESEARCH RESULTS FOR THE LOCAL TREATMENT OF EARLY-STAGE BREAST-CANCER [J].
ABRAMS, JS ;
PHILLIPS, PH ;
FRIEDMAN, MA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (24) :1837-1845
[2]   THE IMPACT OF TUMOR SIZE AND HISTOLOGY ON LOCAL-CONTROL AFTER BREAST-CONSERVING THERAPY [J].
BARTELINK, H ;
BORGER, JH ;
VANDONGEN, JA ;
PETERSE, JL .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (04) :297-303
[3]   RISK-FACTORS IN BREAST-CONSERVATION THERAPY [J].
BORGER, J ;
KEMPERMAN, H ;
HART, A ;
PETERSE, H ;
VANDONGEN, J ;
BARTELINK, H .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :653-660
[4]   IDENTIFICATION OF PATIENTS WHO ARE AT HIGH-RISK FOR LOCOREGIONAL BREAST-CANCER RECURRENCE AFTER CONSERVATIVE SURGERY AND RADIOTHERAPY - A REVIEW ARTICLE FOR SURGEONS, PATHOLOGISTS, AND RADIATION AND MEDICAL ONCOLOGISTS [J].
CLARKE, DH ;
MARTINEZ, AA .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :474-483
[5]  
COOPER HS, 1978, CANCER, V42, P2334, DOI 10.1002/1097-0142(197811)42:5<2334::AID-CNCR2820420534>3.0.CO
[6]  
2-1
[7]   WELL-DIFFERENTIATED (TUBULAR) CARCINOMA OF THE BREAST - A CLINICOPATHOLOGIC STUDY OF 145 PURE AND MIXED CASES [J].
DEOS, PH ;
NORRIS, HJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1982, 78 (01) :1-7
[8]  
FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P1717, DOI 10.1002/1097-0142(19860501)57:9<1717::AID-CNCR2820570902>3.0.CO
[9]  
2-H
[10]   Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial [J].
Forrest, AP ;
Stewart, HJ ;
Everington, D ;
Prescott, RJ ;
McArdle, CS ;
Harnett, AN ;
Smith, DC ;
George, WD .
LANCET, 1996, 348 (9029) :708-713